跳到主内容Skip to content
Debunking Matrix
The claimEvidence B · meta-analysis

Diet soda is a healthy substitute

The evidence

The World Health Organization (2023) conditionally advises against non-sugar sweeteners for weight control; the International Agency for Research on Cancer lists aspartame as Group 2B (possibly carcinogenic); in the Suez 2022 trial, saccharin and sucralose worsened blood-sugar responses.

The mechanism, in brief

Under a sugar-free label sit two completely different families. Tell them apart and you can predict whether a whole bar of sugar-free chocolate will send you to the toilet.

Sources (4)
  • World Health Organization. (2023). Use of non-sugar sweeteners: WHO guideline. Geneva: WHO. Recommendation: WHO suggests that non-sugar sweeteners not be used as a means of achieving weight control or reducing the risk of noncommunicable diseases (conditional recommendation). The underlying systematic review identified 283 unique studies (50 RCTs, 97 prospective cohorts, 47 case-control studies). It does not cover people with pre-existing diabetes (out of scope), low-calorie sugars and sugar alcohols (polyols), or NSS in medicines and personal-care products (guideline PDF, WHO IRIS, Wayback snapshot 26 July 2025).
  • Schiffman, S. S., Scholl, E. H., Furey, T. S., & Nagle, H. T. (2023). Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: in vitro screening assays. Journal of Toxicology and Environmental Health, Part B, 26(6), 307-341. In-vitro screening reported genotoxicity for sucralose-6-acetate, a compound that arises as a manufacturing impurity of sucralose and can also be formed when gut bacteria acetylate sucralose. The work is cell-based screening, not human exposure data.
  • International Agency for Research on Cancer. (2023). IARC Monographs evaluation of the carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lyon: IARC.
  • Toews, I., Lohner, S., Kullenberg de Gaudry, D., Sommer, H., & Meerpohl, J. J. (2019). Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ, 364, k4718. In adults, non-sugar sweetener intake produced a small reduction in body mass index (mean difference -0.6; 95% CI -1.19 to -0.01) from two studies in 174 participants. The authors rate the certainty of evidence across outcomes as low to very low, and report no evidence of benefit for most health outcomes studied.
Go deeperRead the full mechanism →

Related debunks